Unknown

Dataset Information

0

Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson's Disease Mouse Model.


ABSTRACT: Parkinson's disease (PD) is the second most common neurodegenerative disease, which is clinically and pathologically characterized by motor dysfunction and the loss of dopaminergic neurons in the substantia nigra, respectively. PD treatment with stem cells has long been studied by researchers; however, no adequate treatment strategy has been established. The results of studies so far have suggested that stem cell transplantation can be an effective treatment for PD. However, PD is a progressively deteriorating neurodegenerative disease that requires long-term treatment, and this has been insufficiently studied. Thus, we aimed to investigate the therapeutic potential of human adipose-derived stem cells (hASC) for repeated vein transplantation over long-term in an animal model of PD. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD model mice, hASCs were administered on the tail vein six times at two-week intervals. After the last injection of hASCs, motor function significantly improved. The number of dopaminergic neurons present in the nigrostriatal pathway was recovered using hASC transplantation. Moreover, the administration of hASC restored altered dopamine transporter expression and increased neurotrophic factors, such as brain-derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factor (GDNF), in the striatum. Overall, this study suggests that repeated intravenous transplantation of hASC may exert therapeutic effects on PD by restoring BDNF and GDNF expressions, protecting dopaminergic neurons, and maintaining the nigrostriatal pathway.

SUBMITTER: Park H 

PROVIDER: S-EPMC7663651 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2007-01-01 | S-EPMC1808500 | BioStudies
2019-01-01 | S-EPMC6690717 | BioStudies
2011-01-01 | S-EPMC6623418 | BioStudies
2020-01-01 | S-EPMC7458523 | BioStudies
1000-01-01 | S-EPMC6082872 | BioStudies
2008-01-01 | S-EPMC2579941 | BioStudies
2015-01-01 | S-EPMC4346478 | BioStudies
2020-01-01 | S-EPMC7037114 | BioStudies
2019-01-01 | S-EPMC6371654 | BioStudies
1000-01-01 | S-EPMC5882968 | BioStudies